UHPLC Analysis of mAbs

March 13, 2020
YMC Europe GmbH

Sponsored Content - EU

This note using YMC-Triart Bio C4 shows a robust separation at high temperatures for three commercially available mAbs: ofatumumab, palivizumab, and panitumumab.